サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1776221

神経血管血栓除去デバイス/脳血栓除去デバイスの世界市場 - 市場考察、競合情勢、市場予測（2032年）

Neurovascular Thrombectomy Devices/Neurothrombectomy Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

出版日
発行
DelveInsight
ページ情報
英文 150 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.39円
神経血管血栓除去デバイス/脳血栓除去デバイスの世界市場 - 市場考察、競合情勢、市場予測（2032年）
出版日: 2025年07月01日
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の神経血管血栓除去デバイス/脳血栓除去デバイスの市場規模は、2024年に8億4,970万米ドルであり、2032年までに14億3,478万米ドルに達すると予測され、2025年～2032年の予測期間にCAGRで6.88%の成長が見込まれます。神経疾患、特に脳卒中の負担の増大が神経血管血栓除去デバイス市場を大きく押し上げています。これと同時に、高血圧、糖尿病、肥満の増加が、脳卒中やその他の神経障害のリスクをさらに悪化させています。これらの状態は脳卒中の確立された危険因子であり、急性虚血性イベントの高い発生率につながり、その結果、血栓除去デバイスの需要が増加しています。しかし、機械的血栓除去デバイスの認知度向上と採用が市場をさらに押し上げています。さらに、市場の主要企業は、革新的な神経血管血栓除去デバイス/脳血栓除去デバイスを導入するための研究開発に継続的に投資しており、パートナーシップや共同研究の増加、製品の上市、承認により、2025年～2032年の予測期間に市場は引き続きダイナミックで革新的なものとなります。

神経血管血栓除去デバイス/脳血栓除去デバイスの市場力学

British Heart Foundation（2025）が提供した最新データによると、約4,600万人の女性と約4,800万人の男性が元脳卒中患者でした。

また、World Stroke Organization（2025）の最新データによると、毎年約1,220万人が新たに脳卒中を発症しています。世界全体では、26歳以上の4人に1人が生涯のうちに脳卒中を発症します。

脳卒中の患者数が増加していることから、病院や専門治療センターでは、血流を回復させる救命ソリューションとして、これらのデバイスの採用が進んでいます。脳血管を閉塞している血栓を除去するように設計された神経血管血栓除去デバイスは、脳損傷を最小化し、患者の予後を向上させるために迅速な介入が不可欠である急性虚血性脳卒中の管理において極めて重要なものとなっています。その結果、脳卒中患者の急増が神経血管血栓除去デバイス市場全体の成長を促進し、主な医療課題に対処する上でこれらのデバイスが果たす重要な役割を浮き彫りにしています。

さらに、世界保健機関（WHO）（2024）が提供したデータや統計によると、2022年に世界の8人に1人が肥満症を抱えて生活していました。約25億人の18歳以上の成人が過体重で、そのうち8億9,000万人が肥満症と共存しています。18歳以上の成人のうち、43%が過体重で、16%が肥満症を抱えて生活していました。さらに、2022年に5歳未満の子供の3,700万人が過体重です。過体重の有病率は年長の子供や青少年でも顕著で、5～19歳の3億9,000万人以上が過体重で、そのうち1億6,000万人が肥満症を抱えていました。

肥満は、血栓が脳の血管を閉塞して起こる虚血性脳卒中など、複数の血管疾患の危険因子として確立されています。世界の肥満率の上昇に伴い、脳卒中やその他の関連合併症の罹患率も増加しています。このような患者数の増加は、脳から血栓を除去し、正常な血流を回復させるために使用される神経血管血栓除去デバイスの需要を促進し、市場全体を拡大しています。

さらに、神経血管血栓除去デバイス/脳血栓除去デバイス市場における開発活動の成功が、世界中の市場全体をさらに押し上げます。例えば2025年4月、医療機器と体外診断技術を医療産業に提供する主要プロバイダーであるSurmodics, Inc.は、Pounce（TM）スイートに追加されたPounce（TM）XL Thrombectomy Systemの上市を発表しました。このシステムは、末梢動脈から急性または慢性の血栓を迅速に血管内除去できるように設計されており、血管インターベンションにおける同社のポートフォリオをさらに強化するものです。

このように、上記の要因が予測期間に神経血管血栓除去デバイス/脳血栓除去デバイスの市場を押し上げる可能性が高いです。

しかし、血管穿孔、塞栓症、周囲の脳組織への損傷などの合併症のリスクや、製品承認に対する厳しい規制上の懸念が、神経血管血栓除去デバイス/脳血栓除去デバイスの将来の市場を阻害する可能性があります。

当レポートでは、世界の神経血管血栓除去デバイス/脳血栓除去デバイス市場について調査分析し、市場規模と予測、過去3年の製品/技術開発、市場の主要企業、利用可能な機会などの情報を提供しています。

目次

第1章 神経血管血栓除去デバイス/脳血栓除去デバイス市場レポートのイントロダクション

第2章 神経血管血栓除去デバイス/脳血栓除去デバイス市場のエグゼクティブサマリー

  • 市場の概要

第3章 競合情勢

第4章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第5章 神経血管血栓除去デバイス/脳血栓除去デバイス市場の主な要因の分析

  • 神経血管血栓除去デバイス/脳血栓除去デバイス市場の促進要因
  • 神経血管血栓除去デバイス/脳血栓除去デバイス市場の抑制要因と課題
  • 神経血管血栓除去デバイス/脳血栓除去デバイス市場の機会

第6章 神経血管血栓除去デバイス/脳血栓除去デバイス市場のポーターのファイブフォース分析

第7章 神経血管血栓除去デバイス/脳血栓除去デバイス市場の評価

  • 製品タイプ別
    • クロットリトリーバー
    • ステントリトリーバー
    • 吸引デバイス
    • その他
  • 機能別
    • 機械的非吸引
    • 機械的吸引
  • 用途別
    • 末梢血管血栓除去
    • 冠動脈血栓除去
    • 神経血管血栓除去
  • エンドユーザー別
    • 病院・診療所
    • 外来手術センター
  • 地域
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第8章 神経血管血栓除去デバイス/脳血栓除去デバイス市場の企業と製品のプロファイル

  • Stryker
  • Penumbra, Inc.
  • Vesalio, LLC.
  • Acandis GmbH
  • Rapid Medical
  • Johnson & Johnson
  • Teleflex Incorporated
  • Medtronic PLC
  • NeuroVasc Technologies, Inc.
  • Perflow Medical
  • Edward LifeSciences Corporation
  • Terumo Europe NV
  • Koninklijke Philips N.V.
  • MicroVention Inc.
  • Phenox GmbH
  • Biomedical Solutions Inc.
  • Ceretrieve Ltd.
  • Anaconda Biomed SL
  • Genesis Medtech
  • Innova Vascular

第9章 KOLの見解

第10章 プロジェクトアプローチ

第11章 DelveInsightについて

第12章 免責事項と連絡先

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Global (2022-2032)
  • Table 3: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Global by Product Type (2022-2032)
  • Table 4: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Global by Function (2022-2032)
  • Table 5: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Global by Application (2022-2032)
  • Table 6: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Global by End-User (2022-2032)
  • Table 7: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Global by Geography (2022-2032)
  • Table 8: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in North America (2022-2032)
  • Table 9: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in the United States (2022-2032)
  • Table 10: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Canada (2022-2032)
  • Table 11: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Mexico (2022-2032)
  • Table 12: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Europe (2022-2032)
  • Table 13: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in France (2022-2032)
  • Table 14: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Germany (2022-2032)
  • Table 15: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in United Kingdom (2022-2032)
  • Table 16: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Italy (2022-2032)
  • Table 17: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Spain (2022-2032)
  • Table 18: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in the Rest of Europe (2022-2032)
  • Table 19: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Asia-Pacific (2022-2032)
  • Table 20: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in China (2022-2032)
  • Table 21: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Japan (2022-2032)
  • Table 22: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in India (2022-2032)
  • Table 23: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Australia (2022-2032)
  • Table 24: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in South Korea (2022-2032)
  • Table 25: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Rest of Asia-Pacific (2022-2032)
  • Table 26: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in the Rest of the World (2022-2032)
  • Table 27: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in the Middle East (2022-2032)
  • Table 28: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Africa (2022-2032)
  • Table 29: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in South America (2022-2032)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Global (2022-2032)
  • Figure 3: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Global by Product Type (2022-2032)
  • Figure 4: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Global by Function (2022-2032)
  • Figure 5: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Global by Application (2022-2032)
  • Figure 6: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Global by End-User (2022-2032)
  • Figure 7: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Global by Geography (2022-2032)
  • Figure 8: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in North America (2022-2032)
  • Figure 9: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in the United States (2022-2032)
  • Figure 10: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Canada (2022-2032)
  • Figure 11: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Mexico (2022-2032)
  • Figure 12: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Europe (2022-2032)
  • Figure 13: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in France (2022-2032)
  • Figure 14: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Germany (2022-2032)
  • Figure 15: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in United Kingdom (2022-2032)
  • Figure 16: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Italy (2022-2032)
  • Figure 17: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Spain (2022-2032)
  • Figure 18: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in the Rest of Europe (2022-2032)
  • Figure 19: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Asia-Pacific (2022-2032)
  • Figure 20: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in China (2022-2032)
  • Figure 21: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Japan (2022-2032)
  • Figure 22: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in India (2022-2032)
  • Figure 23: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Australia (2022-2032)
  • Figure 24: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in South Korea (2022-2032)
  • Figure 25: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Rest of Asia-Pacific (2022-2032)
  • Figure 26: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in the Rest of the World (2022-2032)
  • Figure 27: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in the Middle East (2022-2032)
  • Figure 28: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Africa (2022-2032)
  • Figure 29: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in South America (2022-2032)
  • Figure 30: Market Drivers
  • Figure 31: Market Barriers
  • Figure 32: Market Opportunities
  • Figure 33: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0102

Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market by Product Type (Clot Retrievers, Stent Retrievers, Aspiration Devices, and Others), Function (Mechanical Non-aspiration and Mechanical Aspiration), Application (Peripheral Vascular Thrombectomy, Coronary Vascular Thrombectomy, and Neurovascular Thrombectomy), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the rising burden of neurological disorders such as stroke, increase in cases of hypertension, diabetes, obesity, growing awareness and adoption of mechanical thrombectomy, and increase in product launches and approvals by key market players across the globe.

The neurovascular thrombectomy devices/neurothrombectomy devices market was valued at USD 849.70 million in 2024, growing at a CAGR of 6.88% during the forecast period from 2025 to 2032 to reach USD 1,434.78 million by 2032. The rising burden of neurological disorders, particularly stroke, is significantly boosting the market for neurovascular thrombectomy devices as these are the medical instruments used to remove blood clots from the blood vessels in the brain. Concurrent with this, the rise in cases of hypertension, diabetes, and obesity further exacerbates the risk of stroke and other neurological disorders. These conditions are well-established risk factors for stroke, leading to a higher incidence of acute ischemic events and, consequently, an increased demand for thrombectomy devices. However, the growing awareness and adoption of mechanical thrombectomy devices have further boosted the market. Furthermore, key market players continuously investing in research and development to introduce innovative neurovascular thrombectomy devices/neurothrombectomy devices, increased partnerships and collaborations, product launches, and approvals ensure that the market remains dynamic and innovative, during the forecast period from 2025 to 2032.

Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Dynamics:

According to the recent data provided by the British Heart Foundation (2025), around 46 million women and 48 million men were stroke survivors.

Additionally, as per the latest data provided by the World Stroke Organization (2025), approximately, 12.2 million new strokes occur each year. Globally, one in four people over age 25 will have a stroke in their lifetime.

The escalating number of stroke cases leads to greater adoption of these devices in hospitals and specialized treatment centers, as they offer a life-saving solution for restoring blood flow. Neurovascular thrombectomy devices, which are designed to remove clots obstructing brain blood vessels, become crucial in managing acute ischemic stroke, a condition where rapid intervention is essential to minimize brain damage and improve patient outcomes. As a result, the surge in stroke cases drives the overall growth of the neurovascular thrombectomy device market, highlighting the critical role these devices play in addressing a major healthcare challenge.

Additionally, as per the data and stats provided by the World Health Organization (2024), in 2022, 1 in 8 people worldwide were living with obesity. Approximately, 2.5 billion adults aged 18 years and older were overweight, with 890 million of them living with obesity. Among adults aged 18 years and over, 43% were overweight, and 16% were living with obesity. Additionally, 37 million children under the age of 5 were overweight in 2022. The prevalence of overweight was also significant among older children and adolescents, with over 390 million individuals aged 5-19 years being overweight, including 160 million who were living with obesity.

Obesity is a well-established risk factor for several vascular diseases, including ischemic stroke, which occurs when a blood clot obstructs a blood vessel in the brain. As the global obesity rates rise, there is a corresponding increase in the incidence of stroke and other related complications. This growing patient population drives demand for neurovascular thrombectomy devices, which are used to remove blood clots from the brain and restore normal blood flow thereby escalating the overall market.

Furthermore, the successful developmental activities in the neurovascular thrombectomy devices/neurothrombectomy devices market further boost the overall market across the globe. For instance, in April 2025, Surmodics, Inc., a leading provider of medical devices and in vitro diagnostic technologies to the healthcare industry, announced the commercial launch of the Pounce(TM) XL Thrombectomy System, an advanced addition to its Pounce(TM) suite. The system was designed to enable rapid endovascular removal of acute or chronic thrombus from peripheral arteries, further strengthening the company's portfolio in vascular intervention.

Thus, the factors mentioned above are likely to boost the market of neurovascular thrombectomy devices/neurothrombectomy devices during the forecasted period.

However, the risk of complications such as vessel perforation, embolism, or damage to surrounding brain tissue and stringent regulatory concerns for product approval may hinder the future market of neurovascular thrombectomy devices/neurothrombectomy devices.

Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Segment Analysis:

Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market by Product Type (Clot Retrievers, Stent Retrievers, Aspiration Devices, and Others), Function (Mechanical Non-aspiration and Mechanical Aspiration), Application (Peripheral Vascular Thrombectomy, Coronary Vascular Thrombectomy, and Neurovascular Thrombectomy), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the neurovascular thrombectomy devices/neurothrombectomy devices market, clot retrievers are projected to hold a considerable market share in 2024. Clot retrievers are significantly boosting the overall market of neurovascular thrombectomy devices by revolutionizing the treatment of ischemic strokes. These devices, designed to mechanically remove blood clots from the brain's blood vessels, have enhanced the efficacy of thrombectomy procedures. Their advanced design and functionality enable more effective and reliable clot retrieval, which improves patient outcomes and increases the likelihood of complete recanalization of obstructed vessels. This has led to a broader adoption of thrombectomy as a standard treatment for acute ischemic stroke, thereby driving demand for these devices. The success of clot retrievers has also spurred innovation, leading to the development of newer, more sophisticated models with improved performance characteristics.

Additionally, clinical studies demonstrating the benefits of clot retrievers in reducing disability and mortality have increased their acceptance among healthcare professionals, further contributing to market growth. As more hospitals and stroke centers adopt these technologies, the market for neurovascular thrombectomy devices expands, driven by the increased emphasis on timely and effective stroke intervention.

This growth is also supported by ongoing research and development efforts, and other product development activities across the globe which continue to refine and enhance clot retrieval technologies, ensuring their continued relevance and effectiveness in stroke care. For instance, in June 2023, Innova Vascular received FDA clearance for two new thrombectomy devices Laguna Clot Retriever(TM) System and the Malibu Aspiration Catheter(TM) System. This system is indicated for non-surgical removal of emboli or thrombi, and/or infusing, injecting, or aspirating fluids into or from blood vessels in the peripheral vasculature.

Therefore, owing to the above-mentioned factors, the clot retriever category is expected to generate considerable revenue thereby pushing the overall growth of the global neurovascular thrombectomy devices/neurothrombectomy devices market during the forecast period.

North America is expected to dominate the overall neurovascular thrombectomy devices/neurothrombectomy devices market:

North America is expected to account for the highest proportion of the neurovascular thrombectomy devices/neurothrombectomy devices market in 2024, out of all regions. This can be ascribed to the increasing prevalence of stroke, obesity, hypertension, diabetes, and others, increased government initiatives coupled with increased awareness programs for neurovascular disease, and the presence of key market players engaged in merger, acquisition, product launches, and other market activities across the region are expected to escalate the market of neurovascular thrombectomy devices/neurothrombectomy devices.

According, to the latest data provided by the Centre for Disease Control and Prevention (2024), in the United States, a stroke occurs every 40 seconds, with more than 795,000 people experiencing a stroke annually. Of these, approximately 610,000 were first or new strokes, while around 185,000, or nearly 1 in 4, involved individuals had a previous stroke. Ischemic strokes, which result from blocked blood flow to the brain, accounted for about 87% of all stroke cases.

Additionally, as per the recent data provided by the Centre for Disease Control and Prevention (2024), nearly half of the adults in the United States, totaling 116 million, had hypertension, with the majority 92.1 million having their condition not under control.

Furthermore, as per the recent data provided by the Centre for Disease Control and Prevention (2024), approximately, 38.4 million people of all ages, representing 11.6% of the U.S. population, had diabetes.

Diabetes and hypertension are major risk factors for stroke, leading to an increased demand for effective treatments to manage and mitigate these risks. Neurovascular thrombectomy devices, which are used to remove blood clots from the brain's blood vessels, become increasingly critical as the incidence of stroke rises. This growing demand for thrombectomy procedures drives the market for these devices, as healthcare providers seek advanced tools to enhance patient outcomes and reduce the impact of strokes. Consequently, the prevalence of diabetes and hypertension directly contributes to the market expansion of neurovascular thrombectomy devices across the region.

Moreover, the increase in product development activities and ongoing research and development further escalates the market of neurovascular thrombectomy devices/neurothrombectomy devices across the region. For instance, in February 2024, Innova Vascular announced the successful early commercial use of Laguna Thrombectomy System(TM) in patients.

Therefore, the above-mentioned factors are expected to bolster the growth of the neurovascular thrombectomy devices/neurothrombectomy devices market in North America during the forecast period.

Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Key Players:

Some of the key market players operating in the neurovascular thrombectomy devices/neurothrombectomy devices market include Stryker, Penumbra, Inc., Vesalio, LLC., Acandis GmbH, Rapid Medical, Johnson & Johnson Services Inc., Teleflex Incorporated, Medtronic, NeuroVasc Technologies, Inc., Perflow Medical, Edward LifeSciences Corporation, Terumo Corporation, Koninklijke Philips N.V., MicroVention Inc., phenox GmbH, Biomedical Solutions Inc., Ceretrieve Ltd., Anaconda Biomed SL, Genesis Medtech., Innova Vascular, and others.

Recent Developmental Activities in the Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market:

  • In February 2023, Phenox Inc. received FDA 510(k) clearance for its pRESET(R) Thrombectomy Device, a minimally invasive tool designed to remove blood clots in patients with acute ischemic stroke. This minimally invasive device is designed to effectively remove blood clots from blocked brain arteries, helping to rapidly restore blood flow and minimize brain damage.
  • In September 2022, Vesalio announced the CE Approval for the new NeVa NET(TM). NeVa Net(TM) micro-filtration technology is coupled with NeVa's Drop Zone(TM) technology which creates a one-of-a-kind stent retriever designed to capture every type of clot and maximize clot retention for fast and effective recanalization of ischemic tissue.

Key takeaways from the neurovascular thrombectomy devices/neurothrombectomy devices market report study:

  • Market size analysis for current neurovascular thrombectomy devices/neurothrombectomy devices size (2024), and market forecast for 8 years (2025 to 2032)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the neurovascular thrombectomy devices/neurothrombectomy devices market.
  • Various opportunities available for the other competitors in the neurovascular thrombectomy devices/neurothrombectomy devices market space.
  • What are the top-performing segments in 2024? How these segments will perform in 2032?
  • Which are the top-performing regions and countries in the current neurovascular thrombectomy devices/neurothrombectomy devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for neurovascular thrombectomy devices/neurothrombectomy devices market growth in the coming future?

Target audience who can benefit from this neurovascular thrombectomy devices/neurothrombectomy devices market report study:

  • Neurovascular thrombectomy devices/neurothrombectomy devices product providers
  • Research organizations and consulting companies
  • Neurovascular thrombectomy devices/neurothrombectomy devices-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in neurovascular thrombectomy devices/neurothrombectomy devices
  • Various end-users who want to know more about the neurovascular thrombectomy devices/neurothrombectomy devices market and the latest technological developments in the neurovascular thrombectomy devices/neurothrombectomy devices market.

Frequently Asked Questions for the Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market:

1. What are neurovascular thrombectomy devices/neurothrombectomy devices?

  • Neurovascular thrombectomy devices, also known as cerebral thrombectomy devices, are used to remove or destroy blood clots in the brain region. These devices are also used in patients where pharmacological treatment has not worked effectively.

2. What is the market for neurovascular thrombectomy devices/neurothrombectomy devices?

  • The neurovascular thrombectomy devices/neurothrombectomy devices market was valued at USD 849.70 million in 2024, growing at a CAGR of 6.88% during the forecast period from 2025 to 2032 to reach USD 1,434.78 million by 2032.

3. What are the drivers for the neurovascular thrombectomy devices/neurothrombectomy devices market?

  • The rising burden of neurological disorders, particularly stroke, is significantly boosting the market for neurovascular thrombectomy devices as these are the medical instruments used to remove blood clots from the blood vessels in the brain. Concurrent with this, the rise in cases of hypertension, diabetes, and obesity further exacerbates the risk of stroke and other neurological disorders. These conditions are well-established risk factors for stroke, leading to a higher incidence of acute ischemic events and, consequently, an increased demand for thrombectomy devices. However, the growing awareness and adoption of mechanical thrombectomy devices have further boosted the market. Furthermore, key market players continuously investing in research and development to introduce innovative neurovascular thrombectomy devices/neurothrombectomy devices, increased partnerships and collaborations, product launches, and approvals ensure that the market remains dynamic and innovative, during the forecast period from 2025 to 2032.

4. Who are the key players operating in the neurovascular thrombectomy devices/neurothrombectomy devices market?

  • Some of the key market players operating in the neurovascular thrombectomy devices/neurothrombectomy devices market include Stryker, Penumbra, Inc., Vesalio, LLC., Acandis GmbH, Rapid Medical, Johnson & Johnson Services Inc., Teleflex Incorporated, Medtronic, NeuroVasc Technologies, Inc., Perflow Medical, Edward LifeSciences Corporation, Terumo Corporation, Koninklijke Philips N.V., MicroVention Inc., phenox GmbH, Biomedical Solutions Inc., Ceretrieve Ltd., Anaconda Biomed SL, Genesis Medtech, Innova Vascular, and others.

5. Which region has the highest share in the neurovascular thrombectomy devices/neurothrombectomy devices market?

  • North America is expected to account for the highest proportion of the neurovascular thrombectomy devices/neurothrombectomy devices market in 2024, out of all regions. This can be ascribed to the increasing prevalence of stroke, obesity, hypertension, diabetes, and others, increased government initiatives coupled with increased awareness programs for neurovascular disease, and the presence of key market players engaged in merger, acquisition, product launches, and other market activities across the region are expected to escalate the market of neurovascular thrombectomy devices/neurothrombectomy devices.

Table of Contents

1. Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Key Factors Analysis

  • 5.1. Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Drivers
    • 5.1.1. The rising burden of neurological disorders such as stroke
    • 5.1.2. Increase in cases of hypertension, diabetes, obesity
    • 5.1.3. Growing awareness and adoption of mechanical thrombectomy
    • 5.1.4. Increase in product launches and approvals by key market players across the globe.
  • 5.2. Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Restraints and Challenges
    • 5.2.1. The risk of complications such as vessel perforation, embolism, or damage to surrounding brain tissue
    • 5.2.2. Stringent regulatory concerns for product approval
  • 5.3. Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Opportunities
    • 5.3.1. Ongoing research and development in improving clot retrieval mechanisms and enhanced imaging integration

6. Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Assessment

  • 7.1. By Product Type
    • 7.1.1. Clot Retrievers
    • 7.1.2. Stent Retrievers
    • 7.1.3. Aspiration Devices
    • 7.1.4. Others
  • 7.2. By Function
    • 7.2.1. Mechanical Non-aspiration
    • 7.2.2. Mechanical Aspiration
  • 7.3. By Application
    • 7.3.1. Peripheral Vascular Thrombectomy
    • 7.3.2. Coronary Vascular Thrombectomy
    • 7.3.3. Neurovascular Thrombectomy
  • 7.4. By End-User
    • 7.4.1. Hospitals & Clinics
    • 7.4.2. Ambulatory Surgical Centers
    • 7.4.3. Others
  • 7.5. By Geography
    • 7.5.1. North America
      • 7.5.1.1. United States Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Size in USD million (2022-2032)
      • 7.5.1.2. Canada Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Size in USD million (2022-2032)
      • 7.5.1.3. Mexico Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Size in USD million (2022-2032)
    • 7.5.2. Europe
      • 7.5.2.1. France Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Size in USD million (2022-2032)
      • 7.5.2.2. Germany Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Size in USD million (2022-2032)
      • 7.5.2.3. United Kingdom Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Size in USD million (2022-2032)
      • 7.5.2.4. Italy Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Size in USD million (2022-2032)
      • 7.5.2.5. Spain Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Size in USD million (2022-2032)
      • 7.5.2.6. Rest of Europe Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Size in USD million (2022-2032)
    • 7.5.3. Asia-Pacific
      • 7.5.3.1. China Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Size in USD million (2022-2032)
      • 7.5.3.2. Japan Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Size in USD million (2022-2032)
      • 7.5.3.3. India Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Size in USD million (2022-2032)
      • 7.5.3.4. Australia Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Size in USD million (2022-2032)
      • 7.5.3.5. South Korea Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Size in USD million (2022-2032)
      • 7.5.3.6. Rest of Asia-Pacific Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Size in USD million (2022-2032)
    • 7.5.4. Rest of the World (RoW)
      • 7.5.4.1. Middle East Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Size in USD million (2022-2032)
      • 7.5.4.2. Africa Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Size in USD million (2022-2032)
      • 7.5.4.3. South America Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Size in USD million (2022-2032)

8. Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Company and Product Profiles

  • 8.1. Stryker
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Penumbra, Inc.
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Vesalio, LLC.
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Acandis GmbH
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Rapid Medical
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Johnson & Johnson
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Teleflex Incorporated
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Medtronic PLC
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. NeuroVasc Technologies, Inc.
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Perflow Medical
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Edward LifeSciences Corporation
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Terumo Europe NV
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Koninklijke Philips N.V.
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. MicroVention Inc.
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Phenox GmbH
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. Biomedical Solutions Inc.
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. Ceretrieve Ltd.
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. Anaconda Biomed SL
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. Genesis Medtech
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. Innova Vascular
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact